GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
CytoMed Therapeutics Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$0.85−0.03 (-3.17%)
Close on Oct 19, 2026
Dividends
CytoMed Therapeutics has not reported a dividend
No dividend per share appears in CytoMed Therapeutics's annual filings since fiscal 2019.